1. Kanters A, Vu J, Schuman A, Van Wieren I, Duby A, Hardiman K, Hendren S: Completeness of operative reports for rectal cancer surgery. American Journal of Surgery. In Press.
  2. Hendren S, Vu J, Suwanabol P, Kamdar N, Hardiman, KM: Hospital variation in readmissions and visits to the emergency department following ileostomy surgery: a population-based cohort study. J of Gastrointestinal Surgery. In Press.
  3. De Roo AC, Morris AM, Vu JV, Schuman A, Abbott K, Kandagatla P, Hardiman KM, Hendren S: Characteristics of Patients Seeking Second Opinions at a Multidisciplinary Colorectal Cancer Clinic. Dis Colon Rectum. In Press.
  4. Frydrych L, Ulintz P, Bankhead A, Sifuentes C, Greenson J, Maguire L, Irwin R, Fearon ER, Hardiman KM: Rectal Cancer Sub-Clones Respond Differentially to Neoadjuvant Therapy. Neoplasia. In press.
  5. Maguire L, Geiger T, Hardiman KM, Regenbogen SE, Hopkins B, Muldoon R, Hawkins A: Surgical Management of Primary Lymphoma: Big Data for a Rare Problem, J of Surgical Oncology. J Surg Oncol. 2019 Jun 11. doi: 10.1002/jso.25582. [Epub ahead of print]. PM31187517
  6. Hardiman KM, Antunez AG, Kanters A, Schuman AD, Regenbogen SE: Clinical and pathological outcomes of induction chemotherapy before neoadjuvant radiotherapy in locally-advanced rectal cancer Journal of Surgical Oncology. 2019 Apr 16. doi: 10.1002/jso.25474. PM30993710
  7. Vu JV, Matusko N, Hendren S, Regenbogen SE, Hardiman KM: Patient-Reported Unmet Needs in Colorectal Cancer Survivors After Treatment for Curative Intent. Dis Colon Rectum doi: 10.1097/DCR. 000000000000132, 2019. PM30640317
  8. Kandagatla P, Nikolian VC, Matsuoka N, Mason S, Regenbogen SE, Hardiman KM: Assessment of patient-reported outcomes and readmission after ileostomy creation in older adults. American Surgeon 84 (11): 1814-1818, 2018.
  9. Kandagatla P, Maguire LH, Hardiman KM: Biology of Nodal Spread in Colon Cancer: Insights from Molecular and Genetic Studies. Eur Surg Res 59(5-6): 361-370, 2018. PM30537705
  10. Vu JV, De Roo A, Hardiman KM: Can ZEB2 Be Used as a Molecular Marker for Risk Stratification of Patients With Colorectal Cancer? JAMA Netw Open 1(6): e183133, 2018. PM30646215
  11. Hardiman KM: Translational Research in Colorectal Cancer. Clin Colon Rectal Surg 31(3): 145-146, 2018. PM29720899/PMC5930113
  12. Suwanabol PA, Hardiman KM: Prevention and Management of Colostomy Complications: Retraction and Stenosis. Dis Colon Rectum 61(12): 1344-1347, 2018. PM30399047
  13. Hardiman KM: Update on Sporadic Colorectal Cancer Genetics. Clin Colon Rectal Surg 31(3): 147-152, 2018. PM29720900
  14. Ulintz PJ, Greenson JK, Wu R, Fearon ER, Hardiman KM: Lymph Node Metastases in Colon Cancer are Polyclonal Clin Cancer Res online: doi: 10.1158/1078-0432, 2017. PM29203589
  15. Dosch J, Ziemke E, Wan S, Luker K, Welling T, Hardiman K, Fearon E, Thomas S, Flynn M, Rios-Doria J, Hollingsworth R, Herbst R, Hurt E, Sebolt-Leopold J: Targeting ADAM17 inhibits human colorectal adenocarcinoma progression and tumor-initiating cell frequency. Oncotarget 8(39): 65090-65099, 2017. PM29029414/PMC5630314